Gurnee, IL, United States of America

Kamel Egbaria

This inventor holds 1 USPTO granted patent. Top assignees: Micro-Pak, Inc., University of Michigan. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kamel Egbaria: Innovator in Hair Follicle Stimulation

Introduction

Kamel Egbaria is a notable inventor based in Gurnee, Illinois. He has made significant contributions to the field of hair follicle stimulation through his innovative methods and delivery systems. His work focuses on enhancing the effectiveness of therapeutic materials for hair treatment.

Latest Patents

Kamel Egbaria holds a patent for a novel method and delivery system aimed at stimulating hair follicles. This patent involves the use of therapeutic weak acid or base materials that have been modified to increase their hydrophilicity. The therapeutic material is encapsulated in a lipid vesicle, preferably a non-phospholipid lipid vesicle. This method is particularly effective for the topical delivery of minoxidil, a common treatment for hair loss.

Career Highlights

Throughout his career, Kamel has worked with prestigious institutions, including the University of Michigan and Micro-Pak, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for hair follicle stimulation.

Collaborations

Kamel has collaborated with notable individuals in his field, including Norman Weiner and Donald F. Wallach. These collaborations have further enriched his research and development efforts.

Conclusion

Kamel Egbaria's contributions to the field of hair follicle stimulation demonstrate his commitment to innovation and improvement in therapeutic methods. His patented techniques offer promising solutions for those seeking effective hair treatment options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…